Pediatrics Doctors in Hamilton, OH Accepting Medicare

7 Pediatrics doctors found. Showing 1 - 7

Lilliam I. Ortiz, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 903 Nw Washington Blvd Ste A, Hamilton, OH 45013 Phone: 513-454-1111

Wendy Soto, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1430 University Blvd, Hamilton, OH 45011 Phone: 513-896-3456    Fax: 513-785-4495

Dr. Dennis M Anthony, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 5964 Golf Club Ln, Hamilton, OH 45011 Phone: 513-893-1100    Fax: 513-893-1128

Heather Peterson-schempp, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 210 S 2nd St, Hamilton, OH 45011 Phone: 513-454-1111

Mr. Mark E Blankenburg, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 25 North F Street, Hamilton, OH 45013 Phone: 513-868-1011    Fax: 513-868-6170

Marian Owusu-akyaw, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 903 Nw Washington Blvd Ste A, Hamilton, OH 45013 Phone: 513-454-1111

Katherine B Balkowiec, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 903 Nw Washington Blvd, Suite A, Hamilton, OH 45013 Phone: 513-737-6900    Fax: 513-737-6906

News Archive

Study to determine how vitamin D affects cardiac structure, functions in blacks with hypertension

A Wayne State University School of Medicine physician researcher has received a $1.9 million National Institutes of Health grant to study the role of vitamin D in halting and reducing subclinical cardiac damage in African-Americans suffering from high blood pressure.

ImmunoCellular signs licensing agreement with Caltech to develop antigen-specific T-cell technology

ImmunoCellular Therapeutics, Ltd. announced today that it has established a licensing agreement with the California Institute of Technology for exclusive rights to novel technology for the development of certain antigen specific T-cell immunotherapies for the treatment of cancer.

Phase III RE-LY study results to be presented at the European Society of Cardiology Congress

Results of the Phase III RE-LY(R) (Randomized Evaluation of Long-Term Anticoagulant Therapy, Warfarin, Compared to Dabigatran) study will be presented at the European Society of Cardiology (ESC) Congress in Barcelona on Sunday, Aug. 30. The primary objective of RE-LY was to assess the safety and efficacy of the investigational oral direct thrombin inhibitor, dabigatran etexilate, against the current standard therapy, warfarin, for the prevention of stroke in patients with atrial fibrillation (AF).

New ultrasound technique allows dolphin pregnancy evaluations to mirror those in humans

Ultrasound has been used for decades to study dolphin health and much of that work has been pioneered by veterinarians at the National Marine Mammal Foundation.

Read more Medical News

› Verified 5 days ago